Here we investigated the effects of chronic treated with resveratrol, a polyphenol (3,4 ’ ,5-trihydroxystilbene) found in more than 70 plant species and food products such as red grapes, berries and peanuts, or N-PEP-12, a mix of peptides, on arteries in aging rats. Aging rats have shown endothelial dysfunction. Aged Sprague-Dawley rats (18 months old) were treated with resveratrol (20 mg/kg/day by gavage) or N-PEP-12 (60 mg/kg/day by gavage) for 10 weeks. 24 hour s after the last administration of resveratrol or N-PEP-12, the animals were weighed and diastolic and systolic blood pressure was measured by tail-cuff plethysmography. Thoracic and abdominal aorta artery segments were obtained from resveratrol-, N-PEP-12-and vehicle-treated rats and were mounted in isometric tension for isolated vessels. We found that resveratrol and N-PEP-12 improved acetylcholine-induced relaxation in the old animals. These results suggest that chronic administration of resveratrol or N-PEP-12 may in part reduce endothelial dysfunction in the aging .
M. Yadav, S. Jain, A. Bhardwaj, R. Nagpal, M. Puniya, R. Tomar, V. Singh, O. Parkash, G. B. Prasad, F. Marotta and H. Yadav, “Biological and Medicinal Properties of Grapes and Their Bioactive Constituents: An Update,” Journal of Medicinal Food, Vol. 12, No. 3, 2009, pp. 473-484. http://dx.doi.org/10.1089/jmf.2008.0096
Z. Ungvari, G. Kaley, R. de Cabo, W. E. Sonntag and A. Csiszar, “Mechanisms of Vascular Aging: New Perspectives,” Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol. 65, No. 10, 2010, pp. 1028-1041. http://dx.doi.org/10.1093/gerona/glq113
A. Csiszar, Z. Ungvari, J. G. Edwards, P. Kaminski, M. S. Wolin, A. Koller and G. Kaley, “Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function,” Circulation Research, Vol. 90, No. 11, 2002, pp. 1159-1166. http://dx.doi.org/10.1161/01.RES.0000020401.61826.EA
A. Csiszar, N. Labinskyy, Z. Orosz, Z. Xiangmin, R. Buffenstein and Z. Ungvari, “Vascular Aging in the LongestLiving Rodent, the Naked Mole-Rat,” American Journal of Physiology, Vol. 293, No. 2, 2007, pp. H919-H927.
A. J. Donato, I. Eskurza, A. E. Silver, A. S. Levy, G. L. Pierce, P. E. Gates and D. R. Seals, “Direct Evidence of Endothelial Oxidative Stress with Aging in Humans: Relation to Impaired Endothelium Dependent Dilation and Upregulation of Nuclear Factor-KappaB,” Circulation Research, Vol. 100, No. 1, 2007, pp. 1659-1666. http://dx.doi.org/10.1161/01.RES.0000269183.13937.e8
M. Frombaum, S. Le Clanche, D. Bonnefont-Rousselot and D. Borderie, “Antioxidant Effects of Resveratrol and Other Stilbene Derivatives on Oxidative Stress and NO Bioavailability: Potential Benefits to Cardiovascular Diseases,” Biochimie, Vol. 94, No. 2, 2012, pp. 269-276. http://dx.doi.org/10.1016/j.biochi.2011.11.001
X. A. Alvarez, L. Corzo, M. Laredo, C. Sampedro, R. Cacabelos, M. Windisch, H. Moessler and T. H. Crook, “Neuropeptide Dietary Supplement N-PEP-12 Enhances Cognitive Function and Activates Brain Bioelectrical Activity in Healthy Elderly Subjects,” Methods and Findings in Experimental and Clinical Pharmacology, Vol. 27, No. 7, 2005, pp. 483-487. http://dx.doi.org/10.1358/mf.2005.27.7.914776
T. H. Crook, S. H. Ferris, X. A. Alvarez, M. Laredo and H. Moessler, “Effects of N-PEP-12 on Memory among Older Adults,” International Clinical Psychopharmacology, Vol. 20, No. 2, 2005, pp. 97-100. http://dx.doi.org/10.1097/00004850-200503000-00006
D. Volc, A. Alvarez and H. Moessler, “Cognitive Effects of the Novel Neuroprotective Dietary Supplement N-PEP-12: Evidences from a Self-Assessment Study,” Jatros, Neurologie and Psychiatrie, 2005, pp. 1-7.
F. Sanchez, M. de J. Gomez-Villalobos, I. Juárez, L. Quevedo and G. Flores, “Dendritic Morphology on Neurons from Prefrontal Cortex, Hippocampus and Nucleus Accumbens in Altered in Adult Spontaneously Hypertensive Rats,” Synapse, Vol. 65, No. 3, 2011, pp. 198-206. http://dx.doi.org/10.1002/syn.20837
J. G. Lopez-Lopez, J. Moral-Sanz, G. Frazziano, M. J. Gomez-Villalobos, L. Moreno, C. Menendez, J. FloresHernandez, J. A. Lorente, A. Cogolludo and F. PerezVizcaino, “Type 1 Diabetes-Induced Hyper-Responsiveness to 5-Hydroxytryptamine in Rat Pulmonary Arteries via Oxidative Stress and Induction of Cyclooxygenase-2,” Journal of Pharmacology and Experimental Therapeutics, Vol. 338, No. 1, 2011, pp. 400-407. http://dx.doi.org/10.1124/jpet.111.179515
A. G. Rajapakse, G. Yepuri, J. M. Carvas, S. Stein, C. M. Matter, I. Scerri, J. Ruffieux, J. P. Montani, X. F. Ming and Z. Yang, “Hyperactive S6K1 Mediates Oxidative Stress and Endothelial Dysfunction in Aging: Inhibition by Resveratrol,” PLoS One, Vol. 6, No. 4, 2011, e19237. http://dx.doi.org/10.1371/journal.pone.0019237
E. V. Serkina, O. A. Gromova, I. Iu. Torshin, N. Iu. Sotnikova and A. A. Nikonov, “Cerebrolysin Alleviates Perinatal CNS Disorders through the Autoimmune Modulation and Antioxidant Protection,” Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, Vol. 108, No. 11, 2008, pp. 62-66.
J. Behbahani, S. J. Thandapilly, X. L. Louis, Y. Huang, Z. Shao, M. A. Kopilas, P. Wojciechowski, T. Netticadan and H. D. Anderson, “Resveratrol and Small Artery Compliance and Remodeling in the Spontaneously Hypertensive Rat,” American Journal of Hypertension, Vol. 23, No. 12, 2010, pp. 1273-1278. http://dx.doi.org/10.1038/ajh.2010.161
A. M. El-Mowafy, M. Alkhalaf and N. N. Nassar, “Resveratrol Reverses ET-1-Evoked Mitogenic Effects in Human Coronary Arterial Cells by Activating the KinaseG to Inhibit ERK-Enzymes,” International Journal of Cardiology, Vol. 136, No. 3, 2009, pp. 263-269. http://dx.doi.org/10.1016/j.ijcard.2008.04.094
H. J. Ma, Y. K. Cao, Y. X. Liu, R. Wang and Y. M. Wu, “Microinjection of Resveratrol into Rostral Ventrolateral Medulla Decreases Sympathetic Vasomotor Tone through Nitric Oxide and Intracellular Ca2+ in Anesthetized Male Rats,” Acta Pharmacologica Sinica, Vol. 29, No. 6, 2008, pp. 906-912. http://dx.doi.org/10.1111/j.1745-7254.2008.00827.x
M. Subramanian, P. Balasubramanian, H. Garver, C. Northcott, H. Zhao, J. R. Haywood, G. D. Fink, S. M. Mohan Kumar and P. S. Mohan Kumar, “Chronic Estradiol-17β Exposure Increases Superoxide Production in the Rostral Ventrolateral Medulla and Causes Hypertension: Reversal by Resveratrol,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, Vol. 300, No. 6, 2011, pp. R1560-1568. http://dx.doi.org/10.1152/ajpregu.00020.2011
N. Toda and T. Okamura, “Modulation of Renal Blood Flow and Vascular Tone by Neuronal Nitric Oxide Synthase-Derived Nitric Oxide,” Journal of Vascular Research, Vol. 48, No. 1, 2011, pp. 1-10. http://dx.doi.org/10.1159/000317395
P. A. Kroon, A. Iyer, P. Chunduri, V. Chan and L. Brown, “The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential,” Current Medicinal Chemistry, Vol. 17, No. 23, 2010, pp. 2442-2355. http://dx.doi.org/10.2174/092986710791556032
J. W. Rush, J. Quadrilatero, A. S. Levy and R. J. Ford, “Chronic Resveratrol Enhances Endothelium-Dependent Relaxation but Does Not Alter eNOS Levels in Aorta of Spontaneously Hypertensive Rats,” Experimental Biology and Medicine (Maywood), Vol. 232, No. 6, 2007, pp. 814-822.